Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Core Laboratories Inc. /DE/
Next earnings ≈ Jul 31, 2026 · est. from filing cadence
Last earnings +3.2% on 2026-04-29
Mixed signals in the latest filings.
Middling fundamentals and a rich price (~54% above fair value) leave little margin of safety — a wait-and-see.
Sources: SEC EDGAR (CIK 0001958086, latest 10-Q filed 2026-05-01) · EODHD · as of 6/22/2026, 2:56:01 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
Core Laboratories Inc. /DE/ shows $527M in FY2025 revenue (+0.5% YoY), a 5.6% net margin, and 11.2% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $470M | $490M | $510M | $524M | $527M |
| Gross profit | — | — | — | — | — |
| Operating income | $45.3M | $41.5M | $54.6M | $58.6M | $56.5M |
| Net income | $19.7M | $19.5M | $36.7M | $31.4M | $29.7M |
| Diluted EPS | $0.42 | $0.42 | $0.77 | $0.66 | $0.63 |
| Net margin | 4.2% | 4.0% | 7.2% | 6.0% | 5.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-05-01 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Tax | 97.00 @ $14.07 | $1.36K |
| 2026-05-01 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Exercise | 250.00 | |
| 2026-04-01 | Murray Katherine Director | Exercise | 8.07K | |
| 2026-04-01 | ANASTASIO CURT Director | Exercise | 8.07K | |
| 2026-04-01 | Klingensmith Harvey Robert Director | Exercise | 8.07K | |
| 2026-04-01 | Temeng Kwaku Director | Exercise | 8.07K | |
| 2026-04-01 | MARTINOVICH ROBERT F Director | Exercise | 8.07K | |
| 2026-04-01 | Carnes Martha Z. Director | Exercise | 8.07K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.